Bristol Myers Squibb (BMY)

CapEx to Revenue

2.35%

Quarterly · Period ending:

BMY logo

BMY CapEx to Revenue

Latest reported2.35%
BMY Quarterly CapEx/Revenue (0.00% → 2.35%)
High-resolution chart · PNG

BMY capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
5.0117%
3.7321%
5.393%
3.0462%
1.9147%
1.73%
4.6967%
3.0952%
3.5976%
2.5134%
5.1382%
3.8028%
4.763%
3.4638%
7.4082%
4.0713%
3.6417%
2.9913%
5.3856%
3.6849%
3.6526%
3.1344%
5.0166%
3.5746%
3.4833%
2.7264%
5.9113%
4.8431%
4.4444%
3.7756%
7.1166%
4.5073%
4.3897%
3.8113%
7.7824%
5.2208%
6.1458%
4.3838%
7.8652%
5.1868%
5.3846%
3.9122%
6.1038%
4.0809%
4.9919%
4.6786%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.